Trial Profile
A Double blind, Randomized, Placebo controlled, Parallel Group, Prospective, Multicentre Clinical Trial for Evaluation of Efficacy and Safety of Fixed Dose Combination of Minoxidil (5%) plus Finasteride (0.1%) Lipid Solution in Comparison with Minoxidil (5%) Lipid Solution and Finasteride (0.1%) Lipid solution in Adult Male Patients with Androgenetic Alopecia - NA
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Dec 2018
Price :
$35
*
At a glance
- Drugs Finasteride/minoxidil (Primary) ; Finasteride; Minoxidil
- Indications Alopecia
- Focus Therapeutic Use
- Sponsors Intas Pharmaceuticals
- 21 May 2018 Status changed from recruiting to completed.
- 25 Aug 2016 New trial record